Detection of Measurable Residual Disease (MRD) in Peripheral Blood: First Report of a Novel Microfluidic Platform in Patients with Acute Myeloid Leukemia (AML)
Blood (2019) 134 (Supplement_1): 1417.
Currently there are no citedby results. Try again later.
